Myasthenia gravis was the focus of a pilot study examining high-dose chemotherapy and autologous hematopoietic cell transplantation in a patient with severe, treatment-resistant myasthenia gravis.
Read More > https://raredisease.pocn.com/treatment/pilot-study-tests-high-dose-chemotherapy-and-stem-cell-transplant-in-treatment-resistant-myasthenia-gravis/
